MedTrace Logo

Retun-to-school Adaptation Program for Children With Cancer

NCT06389357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-09-29

No results posted yet for this study

Summary

The aim of this action research is to:

Stage 1: Conduct an in-depth investigation into the adaptation challenges faced by children aged 8-17 who are being treated for cancer during their return to school, from both the children's and parents' perspectives;

Stage 2: Develop a structured, evidence-based, and digitally accessible intervention program that addresses these identified needs;

Stage 3: Evaluate the feasibility and effectiveness of the intervention; and

Ultimately, based on all data gathered throughout the implementation process, continuously refine the intervention and analyze participant feedback holistically in order to establish a sustainable support model.

Conditions

  • Childhood Cancer
  • ALL, Childhood
  • AML, Childhood
  • Lymphoma
  • Solid Tumor, Childhood

Interventions

BEHAVIORAL

training and counselling

It includes 4 modules that develop children's communication, coping and social life skills and psychosocial preparation for the return to school process. The modules include theoretical explanations, stories, workshops and counselling sessions. Separate educational modules have been developed for parents, teachers, and peers.

OTHER

Interview

As part of the needs assessment in Phase 1, individual interviews with children with cancer and their parents lasting approximately 20-30 minutes were conducted.

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Gizem Cakir, PhD · Gazi University Nursing Faculty

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-30
Primary Completion
2024-12-06
Completion
2024-12-06

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06389357 on ClinicalTrials.gov